Recruiting Interstitial Lung Disease Studies in Denver
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
This study is open to people with idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF). They can only take part if they have completed treatment in a previous study with a medic...
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
A randomized, double-blind, placebo-controlled clinical study to evaluate the safety and efficacy of 2 doses of inhaled pirfenidone (AP01) versus placebo on top of standard of care in participants wit...
A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.
The ASPIRE trial is a 52 week randomized, double-blind, placebo-controlled, parallel-group, multicenter trial in which the efficacy, safety, and pharmacokinetics of orally administered buloxibutid, ei...
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
The main purpose of the master is to help the research sites and sponsor carry out several clinical trials more efficiently by providing a common research protocol. Individual clinical trials under th...
About Interstitial Lung Disease Clinical Trials in Denver
Interstitial lung disease is a group of disorders characterized by progressive scarring of lung tissue, leading to breathlessness and reduced oxygen exchange. Causes include autoimmune diseases, environmental exposures, and unknown factors. Treatment includes antifibrotic medications and immunosuppressants.
There are currently 4 interstitial lung disease clinical trials recruiting participants in Denver, COLORADO. These studies are seeking a combined 2,375 participants. Research is being sponsored by Boehringer Ingelheim, Avalyn Pharma Inc., Vicore Pharma AB and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Interstitial Lung Disease Clinical Trials in Denver — FAQ
Are there interstitial lung disease clinical trials in Denver?
Yes, there are 4 interstitial lung disease clinical trials currently recruiting in Denver, COLORADO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Denver?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Denver research site will contact you about next steps.
Are clinical trials in Denver free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Denver studies also compensate for your time and travel.
What interstitial lung disease treatments are being tested?
The 4 active trials in Denver are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial lung disease.
Data updated March 2, 2026 from ClinicalTrials.gov